Investigating the effect of atorvastatin and aspirin on the durability and function of the central venous catheter for dialysis
Phase 3
Recruiting
- Conditions
- Dialysis.Infection due to central venous catheterT80.21
- Registration Number
- IRCT20191104045328N20
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 162
Inclusion Criteria
Candidate patients for central venous catheterization, for whom a tunneled catheter will be implanted.
Surgery performed by a surgeon and resident
Consent to participate in the study
Exclusion Criteria
History of coagulopathy
Existence of high blood pressure at the same time as diabetes
Presence of fatty liver and liver disease based on confirmation by liver enzyme test
The presence of a disease that has contraindications for taking aspirin (such as nasal polyp disease, asthma, allergy to aspirin)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of catheter operation. Timepoint: The beginning of the intervention until 180 days later. Method of measurement: checklist.;Incidence of catheter infection. Timepoint: After the intervention. Method of measurement: checklist.;Occurrence of thrombosis. Timepoint: After the intervention. Method of measurement: Clinical examination and ultrasound.
- Secondary Outcome Measures
Name Time Method 180 days operation. Timepoint: After the intervention. Method of measurement: Checklist.